Discovery of multiple new SARS-CoV-2 MPro inhibitors

By | July 8, 2022
In a recent study posted to the bioRxiv* preprint server, researchers performed an extensive library docking for new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) covalent and non-covalent inhibitors.